Increasing antibody yield and modulating final product quality using the FreedomTM CHO-STM production platform

BMC Proceedings

Meeting Abstract

Steve Gorfien¹  Shawn Barrett¹  Prasad Dhulipala¹  Laurie Donahue-Hjelle¹  Jian Liu²  Shannon Beatty²  Michelle Sabourin²  Graziella Piras²  Shue-Yuan Wang²  Ying Huang²  Peggy Lio²  Peter Slade³  Karsten Winkler⁴  Volker Sandig⁴  Susanne Seitz⁴  Thomas Rose⁴ 

[1] Life Technologies TM, 14072, Grand Island, NY, USA;Life Technologies TM, 21704, Frederick, MD, USA;Life Technologies TM, 97402, Eugene, OR, USA;ProBioGen AG, Goethestrasse 54, 13086, Berlin, Germany;

关键词: Production Platform;    Cell Culture Process;    Productivity Assessment;    Stable Pool;    Royalty Payment;   

DOI  :  10.1186/1753-6561-5-S8-P102

来源: Springer

【 授权许可】

CC BY   
© Sabourin et al; licensee BioMed Central Ltd. 2011